The data shown below were collected from the profiles of 1,340 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients
|
---|---|
Published in |
Frontiers in Pharmacology, November 2022
|
DOI | 10.3389/fphar.2022.1008946 |
Pubmed ID | |
Authors |
Shin Takayama, Takao Namiki, Ryutaro Arita, Rie Ono, Akiko Kikuchi, Minoru Ohsawa, Natsumi Saito, Satoko Suzuki, Hajime Nakae, Seiichi Kobayashi, Tetsuhiro Yoshino, Tomoaki Ishigami, Koichiro Tanaka, Kotaro Nochioka, Airi Takagi, Masaru Mimura, Takuhiro Yamaguchi, Tadashi Ishii, Akito Hisanaga, Kazuo Mitani, Takashi Ito |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 168 | 13% |
United States | 2 | <1% |
Taiwan | 2 | <1% |
China | 2 | <1% |
Côte d'Ivoire | 1 | <1% |
Timor-Leste | 1 | <1% |
Solomon Islands | 1 | <1% |
Philippines | 1 | <1% |
Austria | 1 | <1% |
Other | 5 | <1% |
Unknown | 1156 | 86% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1326 | 99% |
Scientists | 6 | <1% |
Practitioners (doctors, other healthcare professionals) | 5 | <1% |
Science communicators (journalists, bloggers, editors) | 2 | <1% |
Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 12 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 2 | 17% |
Researcher | 2 | 17% |
Student > Ph. D. Student | 1 | 8% |
Professor | 1 | 8% |
Professor > Associate Professor | 1 | 8% |
Other | 0 | 0% |
Unknown | 5 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 2 | 17% |
Nursing and Health Professions | 2 | 17% |
Medicine and Dentistry | 1 | 8% |
Engineering | 1 | 8% |
Unknown | 6 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 729. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2024.
All research outputs
#29,850
of 26,629,686 outputs
Outputs from Frontiers in Pharmacology
#9
of 20,628 outputs
Outputs of similar age
#864
of 448,423 outputs
Outputs of similar age from Frontiers in Pharmacology
#1
of 1,332 outputs
Altmetric has tracked 26,629,686 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,628 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,423 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 1,332 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.